Khaled Nashar is a Nephrology physician affiliated with Allegheny Health Network. OpenAlex indexes 31 publications with 489 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
320 E North Ave Fl 4
Pittsburgh, PA 152124756
Telephone
412-359-3319Provider last certified this registry record 9 Oct 2020.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202551 payments$76,316openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- Ardelyx, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
57.6%Calcium channel blocker17.5%Amlodipine Besylate51%Nifedipine Er50%Part D<11 patientsLoop diuretic10%Furosemide82%Bumetanide18%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
20.7%Corticosteroid8.8%Prednisone100%Part D≥18 patientsProton pump inhibitor8.2%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
15%Short-acting sulfonamides7.7%Sulfamethoxazole-Trimethoprim100%Part D≥15 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3.2%Valganciclovir Hcl100%Part D≥13 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Renal Allograft Malakoplakia: Favorable Outcome with Early Diagnosis and Prolonged Antibiotic Therapy
Indian Journal of Nephrology
2025 - Unusual Cause of Severe Dyspnea Following Kidney Transplantation: Dapsone Induced Simultaneous Methemoglobinemia and Hemolysis
Indian Journal of Nephrology
2025 - Acute Oxalate Nephropathy: An Unusual Cause of Early Post-Transplant Kidney Allograft Dysfunction and Favorable Outcome with Prompt Intervention
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”